A Arimura Selected Research

S-288310

1/2017

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Arimura Research Topics

Disease

4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2002 - 01/2000
4	Infarction (Infarctions) 12/2002 - 01/2000
4	Ischemia 12/2002 - 01/2000
3	Asthma (Bronchial Asthma) 09/2009 - 03/2001
3	Dermatitis 01/2009 - 04/2003
2	Inflammation (Inflammations) 09/2009 - 08/2001
2	Brain Ischemia (Cerebral Ischemia) 12/2002 - 07/2000
2	Allergic Rhinitis 08/2001 - 01/2001
1	Injection Site Reaction 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Respiratory Hypersensitivity 09/2009
1	Pruritus (Itching) 07/2006
1	Atopic Dermatitis (Atopic Eczema) 04/2003
1	Delayed Puberty 11/2002
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 08/2001
1	Sneezing 08/2001
1	Nasal Obstruction 08/2001
1	Hypoxia (Hypoxemia) 06/2001
1	Acute Pain 06/2001
1	Acromegaly 02/2001
1	Stroke (Strokes) 06/2000
1	Ganglion Cysts (Ganglion) 01/2000
1	Hyperthermia 01/2000

Drug/Important Bio-Agent (IBA)

7	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2002 - 01/2000
3	Neuroprotective AgentsIBA 12/2002 - 01/2000
2	Peptides (Polypeptides)IBA 01/2017 - 06/2001
2	7(2- (5- hydroxybenzo(b)thiophen- 3- ylcarbonylamino)- 10- norpinan- 3- yl)hept- 5- enoic acidIBA 09/2009 - 08/2001
2	AllergensIBA 09/2009 - 08/2001
2	Histamine (Histamine Dihydrochloride)FDA Link 07/2006 - 01/2001
2	AntigensIBA 08/2001 - 01/2001
1	Protein Subunit VaccinesIBA 01/2017
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2017
1	PhosphoproteinsIBA 01/2017
1	HLA-A*24:02 antigenIBA 01/2017
1	S-288310IBA 01/2017
1	ProstaglandinsIBA 09/2009
1	prostaglandin D2 receptorIBA 09/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2009
1	Loratadine (Alavert)FDA Link 01/2009
1	Nerve Growth Factor (NGF)IBA 07/2006
1	AntipruriticsIBA 07/2006
1	AntibodiesIBA 04/2003
1	ExotoxinsIBA 04/2003
1	staphylococcal enterotoxin CIBA 04/2003
1	Prostaglandin D2IBA 08/2001
1	AcidsIBA 08/2001
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 08/2001
1	UrocortinsIBA 06/2001
1	Messenger RNA (mRNA)IBA 06/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2001
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 02/2001
1	GTP-Binding Protein alpha SubunitsIBA 02/2001
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2001
1	S 145IBA 01/2001
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 01/2001
1	Therapeutic UsesIBA 07/2000
1	triphenyltetrazoliumIBA 06/2000

Therapy/Procedure

1	Therapeutics 09/2009
1	Injections 12/2002
1	Oral Administration 08/2001